Two gates. Both must pass.
GLP Success does not score clinics on a numeric scale, and we do not pick a winner. We curate a set of clinics that pass two binary gates, pharmacy quality and clinic quality, and present them as roughly equivalent options. Anything that fails either gate is excluded regardless of price.
- Sterile-compounding accreditation
- Enforcement history weighed
- Licensed where it ships
- Disclosed before purchase
- Clinician access on demand
- Dose-ladder support
- Reliable refills & renewal
- Honest cancellation
- Maintenance off-ramp
- Informed consent
The pharmacy gate
The compounder behind a clinic's prescription is the medicine itself. A clinic with a great care experience and a problematic compounder fails this gate.
- Accreditation
- PCAB Sterile accreditation at the compounding facility, or an equivalent third-party sterile-compounding standard. PCAB Sterile is aligned with USP <797> and is the credential that maps to injectable GLP-1 compounding.
- Enforcement history
- FDA enforcement history is weighed, not an automatic disqualifier. Warning letters, Form 483s, and recalls against the compounder are documented on its regulatory record and factor into the pharmacy pillar as a concern signal. A warning letter is a formal FDA notice, not a shutdown order — we publish the record and the dates, and weigh recency, severity, and whether findings were resolved, rather than treating any single letter as terminal.
- State licensure
- Licensed where it ships. A pharmacy dispensing into a state where it holds no license is operating outside its legal footprint, regardless of how clean its FDA record is. We verify licensure state by state against each state board's public lookup, and publish what we verified, what we couldn't, and when we checked.
- Disclosure
- Public disclosure of the compounder on the clinic's site before purchase. Patients should know who fills their prescription without a fight.
The clinic gate
The clinic must support patients over a multi-year journey, not just sell the first month.
- Clinician access
- On demand when something changes: side effects, dose questions, switching products.
- Dose-ladder support
- Full support up to maximum tirzepatide and semaglutide doses, with willingness to slow down or hold.
- Refills & renewal
- Refill reliability and clear renewal terms. No silent auto-renewals on long-term plans.
- Cancellation
- Easy and honest. A cancel button in the portal, no hostage flow.
- Maintenance
- A stated approach to maintenance and off-ramp, not a one-way pipeline to the highest dose forever.
- Informed consent
- Discloses non-FDA-approved status. Does not market compounded GLP-1s as if they were FDA-cleared.
Review integrity check
This is a signal we weigh, not a third gate — a clinic doesn't fail outright for this alone, but it factors into the verdict alongside everything else on the record.
- Organic vs. invited
- Trustpilot publishes, on every company's public profile, the split between invited reviews (the company sent an invitation after a completed transaction) and organic reviews (someone found the company on Trustpilot and wrote a review unprompted). Invited reviews require a real transaction to exist, which makes them hard to fabricate at scale. A heavy skew toward organic reviews is a known review-manipulation vector.
- Our threshold
- Above 40% organic, we flag it as a review-integrity concern on the clinic's page, cited to the Trustpilot profile at the date we checked it.
Corporate address check
The address pattern prints on the board as the Company receipt and is weighed in the verdict. One case is terminal: a company that publishes no business address at all on its own public pages, with no operating location anywhere on the public record, goes on the Do Not Buy list — a patient literally has no published place to reach it or serve a complaint. A published mailbox or registered-agent address is not terminal on its own; it stays a red receipt.
- Where the company says it is
- We audit every clinic's own terms, privacy, and contact pages for a business address, falling back to BBB profiles and state corporate registries only when the company publishes nothing — and that fallback is itself recorded as a disclosure gap. Each record cites where the address was found and the date.
- What the address is
- A real-looking operating location reads green. A registered-agent suite or rented mailbox — the Sheridan and Casper, Wyoming pattern, where one agent's address hosts thousands of unrelated companies — reads red, as does publishing no address at all. We classify the address pattern only; we make no claim about why a company chose it.
Sources
Every claim that places a clinic on the board or the Do Not Buy list links to a public, third-party-verifiable source: an FDA enforcement page, a state board action, a court filing, a regulatory database, or a documented community incident with verifiable counts. We do not exclude clinics on editorial-judgment grounds we can't externally source.
Updates
Listed clinics are re-checked quarterly against the gates. Any clinic that develops a gate-failing condition moves to the Do Not Buy list with the date and source. The list is not curated to favor any particular pharmacy, clinic, or business model.